Actavis plc is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In October 2013, Actavis Inc acquired Warner Chilcott PLC and in connection with the acquisition, Actavis Inc and Warner Chilcott PLC have been combined under a new company, Actavis plc.